These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1513922)

  • 1. Haloperidol in schizophrenic children: early findings from a study in progress.
    Spencer EK; Kafantaris V; Padron-Gayol MV; Rosenberg CR; Campbell M
    Psychopharmacol Bull; 1992; 28(2):183-6. PubMed ID: 1513922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
    J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo.
    Eklund K; Forsman A
    Clin Neuropharmacol; 1991; 14 Suppl 2():S7-12; discussion S12-5. PubMed ID: 1684310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia.
    Lee BJ; Lee JG; Kim YH
    J Psychopharmacol; 2007 Jun; 21(4):421-7. PubMed ID: 17092979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroencephalogram and treatment of hospitalized aggressive children with haloperidol or lithium.
    Bennett WG; Korein J; Kalmijn M; Grega DM; Campbell M
    Biol Psychiatry; 1983 Dec; 18(12):1427-40. PubMed ID: 6362729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial.
    Akhondzadeh S; Nejatisafa AA; Amini H; Mohammadi MR; Larijani B; Kashani L; Raisi F; Kamalipour A
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):1007-12. PubMed ID: 14499318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics.
    Chin CN; Hamid AR; Philip G; Ramlee T; Mahmud M; Zulkifli G; Loh CC; Zakariah MS; Norhamidah MS; Suraya Y; Roslan KA; Chandramohan P; Cheah YC; Leonard AO
    Med J Malaysia; 1998 Dec; 53(4):365-71. PubMed ID: 10971979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scales for the assessment of neuroleptic response in schizophrenic children: specific measures derived from the CPRS.
    Spencer EK; Alpert M; Pouget ER
    Psychopharmacol Bull; 1994; 30(2):199-202. PubMed ID: 7831455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Children with schizophrenia: diagnosis, phenomenology, and pharmacotherapy.
    Spencer EK; Campbell M
    Schizophr Bull; 1994; 20(4):713-25. PubMed ID: 7701278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration.
    Perry R; Campbell M; Adams P; Lynch N; Spencer EK; Curren EL; Overall JE
    J Am Acad Child Adolesc Psychiatry; 1989 Jan; 28(1):87-92. PubMed ID: 2914841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children.
    Anderson LT; Campbell M; Adams P; Small AM; Perry R; Shell J
    J Autism Dev Disord; 1989 Jun; 19(2):227-39. PubMed ID: 2663834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyproheptadine augmentation of haloperidol in chronic schizophrenic patients: a double-blind placebo-controlled study.
    Lee HS; Song DH; Kim JH; Lee YM; Han ES; Yoo KJ
    Int Clin Psychopharmacol; 1995 Jun; 10(2):67-72. PubMed ID: 7673658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol and reduced haloperidol concentrations and psychiatric ratings in schizophrenic patients treated with ascorbic acid.
    Straw GM; Bigelow LB; Kirch DG
    J Clin Psychopharmacol; 1989 Apr; 9(2):130-2. PubMed ID: 2566628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of haloperidol on learning and behavior in autistic children.
    Campbell M; Anderson LT; Small AM; Perry R; Green WH; Caplan R
    J Autism Dev Disord; 1982 Jun; 12(2):167-75. PubMed ID: 7174605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.